EP0938313A4 - METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMORPHISM-ENRICHED (S) -CLIDINIUM - Google Patents

METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMORPHISM-ENRICHED (S) -CLIDINIUM

Info

Publication number
EP0938313A4
EP0938313A4 EP97932350A EP97932350A EP0938313A4 EP 0938313 A4 EP0938313 A4 EP 0938313A4 EP 97932350 A EP97932350 A EP 97932350A EP 97932350 A EP97932350 A EP 97932350A EP 0938313 A4 EP0938313 A4 EP 0938313A4
Authority
EP
European Patent Office
Prior art keywords
enantiomorphism
clidinium
enriched
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932350A
Other languages
German (de)
French (fr)
Other versions
EP0938313A1 (en
Inventor
Vincent L Fabiano
John R Mccullough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0938313A1 publication Critical patent/EP0938313A1/en
Publication of EP0938313A4 publication Critical patent/EP0938313A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97932350A 1996-07-01 1997-06-27 METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMORPHISM-ENRICHED (S) -CLIDINIUM Withdrawn EP0938313A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2092596P 1996-07-01 1996-07-01
US20925P 1996-07-01
PCT/US1997/011259 WO1998000139A1 (en) 1996-07-01 1997-06-27 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-clidinium

Publications (2)

Publication Number Publication Date
EP0938313A1 EP0938313A1 (en) 1999-09-01
EP0938313A4 true EP0938313A4 (en) 2000-02-23

Family

ID=21801321

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932350A Withdrawn EP0938313A4 (en) 1996-07-01 1997-06-27 METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMORPHISM-ENRICHED (S) -CLIDINIUM

Country Status (2)

Country Link
EP (1) EP0938313A4 (en)
WO (1) WO1998000139A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709476B2 (en) * 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4644003A (en) * 1985-04-03 1987-02-17 Research Corporation 3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
HAURI D.: "[Incontinence of urine: Possibilities for pharmacotherapy].", MEDIZINISCHE MONATSSCHRIFT FUR PHARMAZEUTEN, (1984) 7/8 (233-239). CODEN: MMPHDB, XP000863460 *
KOPPENHOEFER B. ET AL: "Separation of enantiomers of drugs by capillary electrophoresis I..gamma.-Cyclodextrin as chiral solvating agent.", JOURNAL OF CHROMATOGRAPHY A, (1995) 717/1-2 (181-190)., XP000605057 *
KOPPENHOEFER, BERNHARD ET AL: "Separation of enantiomers of drugs by capillary electrophoresis Part 4: hydroxypropyl-gamma-cyclodextrin as chiral solvating agent", ELECTROPHORESIS (1997), 18(6), 924-930, XP000863400 *
LIN B C (REPRINT) ET AL: "SEPARATION OF DRUG ENANTIOMERS BY CAPILLARY ELECTROPHORESIS ALPHA-CYCLODEXTRIN AS CHIRAL SOLVATING AGENT", CHROMATOGRAPHIA, (JAN 1996) VOL. 42, NO. 1-2, PP. 106-110. ISSN: 0009-5893., vol. 42, no. 1/2, 1996, DALIAN INST CHEM PHYS, ZHONG SHAN RD 161, DALIAN 116012, PEOPLES R CHINA (Reprint);CHINA PHARMACEUT UNIV, NANJING 250009, PEOPLES R CHINA; UNIV TUBINGEN, INST ORGAN CHEM, D-72076 TUBINGEN, GERMANY, pages 106 - 110, XP000863359 *
LIN, BINGCHENG ET AL: "Investigation of 123 chiral drugs by cyclodextrin-modified capillary electrophoresis", LC-GC (1997), 15(1), 40, 44-46, XP000863469 *
See also references of WO9800139A1 *
YURDAKOK M ET AL: "Treatment of enuresis: a study with imipramine, amitriptyline, chlordiazepoxide- clidinium and piracetam.", TURKISH JOURNAL OF PEDIATRICS, (1986 JUL-SEP) 28 (3) 171-5., XP000863478 *

Also Published As

Publication number Publication date
WO1998000139A1 (en) 1998-01-08
EP0938313A1 (en) 1999-09-01

Similar Documents

Publication Publication Date Title
FI970704L (en) Men's incontinence device
FR2785521B1 (en) SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES
DE69527979D1 (en) URINARY INCONTINENCE DEVICE
EE9700267A (en) Use of α1L-agonists for the treatment of urinary incontinence
BR9710031A (en) Treatment of urinary incontinence using (-s) -Oxybutynin and (s) -Desethyloxybutynin
EP0796078A4 (en) FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION
FR2799554B1 (en) PHOTORESIST ELIMINATION COMPOSITION AND METHOD FOR ELIMINATION OF A PHOTORESIST USING THE SAME
DE69319824D1 (en) Device for regulating urinary incontinence in women
KR960003695U (en) Men's briefs
AU6030999A (en) Method of delivering therapeutic agents to the urethra and an urethral suppository
EP0938313A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMORPHISM-ENRICHED (S) -CLIDINIUM
EP0957916A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMORPHISM-ENRICHED (R) -CLIDINIUM
ITMI931074A0 (en) PROCEDURE AND DEVICE FOR THE DIETARY OPTIMIZATION OF GROWING PIGS
EP0948287A4 (en) URINARY INCONTINENCE DEVICE
FI964019L (en) Quinolone derivative for the treatment of urinary incontinence
FR2759290B1 (en) MINALCIPRAN FOR THE TREATMENT OF URINARY INCONTINENCE
IL115887A0 (en) Pharmaceutical compositions for the treatment of urinary bladder dysfunctions
EP0909170A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERIC ENRICHED (S) -TRIDIHEXETHYL
EP0933992A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMERIC ENRICHED (R) -TRIDIHEXETHYL
FR2749164B1 (en) DEVICE FOR REMOVING URINARY INCONTINENCE
KR970050665U (en) Men's briefs
IL115886A0 (en) Pharmaceutical compositions for the treatment of urinary bladder dysfunctions
KR960028352U (en) Urinary incontinence prevention device for women
EP0691402A3 (en) Modified satellite-RNA's and satellite-viruses as support for adapted ribozymes
KR960003694U (en) Men's briefs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000111

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030103